Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Pharmacol Sci. 2005 May;26(5):225-8.

Androgen receptor-cofactor interactions as targets for new drug discovery.

Author information

  • 1Duke University Medical Center, Department of Pharmacology and Cancer Biology, Durham, NC 27710, USA.

Abstract

Cofactor recruitment is a crucial regulatory step in nuclear receptor signal transduction. Given the obligate nature of interactions between cofactors and these receptors for transcriptional activity, it is likely that drugs that target coactivator interaction surfaces will function as pure antagonists with particular utility in the treatment of estrogen- and androgen-dependent cancers. Recent crystallographic analysis of one of the major protein-protein interaction surfaces on the androgen receptor has raised expectations that it will be possible to develop small-molecule antagonists that block cofactor interactions.

PMID:
15860367
DOI:
10.1016/j.tips.2005.03.002
[PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center